ARTICLES BY SUZANNE HODSDEN
Hill-Rom Unveils Mobile, Connected Airway Clearance System For Patients On the Move
Hill-Rom has unveiled an airway clearance system that is integrated into a mobile vest and allows patients more freedom of movement while receiving their respiratory therapies.
Could Fiber Optic Probes Replace Traditional Biopsies?
Successfully miniaturized multimodal optical technology combines three nonlinear imaging techniques into one probe, said German scientists.
Baxter on “Right Path” for Top Quartile Performance, Says CEO
Baxter topped Q1 expectations and delivered a four percent sales increase that allowed the company to raise its 2017 forecast.
CEO Lobo: Stryker Positioned For Another Strong Year In 2017
Stryker CEO Kevin Lobo reported continued momentum in robotics and 3D printing technology, and told investors he was not concerned about increased competition in either field.
Could Ingestible Sensors Replace Colonoscopies?
A team of Australian scientists has just completed a phase one human clinical trial with an ingestible biosensor that can measure gas produced by the gut, and potentially transmit results to a connected smartphone.
GE Beats Q1 Forecasts On Strength Of Double-Digit Growth In Healthcare Equipment
GE continues to report “solid” performance for its healthcare sector, despite what CEO Jeffrey Immelt called “slow growth in a volatile environment” and challenges in other segments
Smaller, Gentler Brain Electrodes Worth Their Weight In Gold…And Graphene
Scientists in South Korea are mining the biomedical potential of both gold and graphene to design a more flexible brain-machine interface (BMI) that can transmit clearer signals while causing minimal damage to brain tissue, said researchers.
Siemens Healthineers Boosts Population Health Portfolio With Medicalis Buy
Siemens is looking to expand its portfolio of population health management (PHM) solutions with the acquisition of San Francisco-based tech firm Medicalis, which specializes in tools that maximize efficiency in clinical decisions, imaging workflow, and scheduling management.
Medtronic Divests Three Business Units, Inks Deal With Cardinal Health For $6.1 Billion
Medtronic has confirmed a $6.1 billion cash deal with Cardinal Health and the divestment of its patient care, deep vein thrombosis, and nutritional insufficiency businesses, as well as 17 manufacturing facilities. Senior leadership at Medtronic stated they expect the businesses to “thrive” at Cardinal Health.
Verily’s “Study Watch” Specially Designed For Clinical Trials
With Verily’s new “investigative watch,” the only information the clinical trial participant can view is the time and date, but researchers have access to a host of physiological data and biomarkers, including heart rate, activity data, and electrocardiograms (ECGs).